Market Place
Sourcing Support
DBV Technologies Reveals Q2 and Half-Year 2025 Financials
29 Jul 2025 //
GLOBENEWSWIRE
DBV Files 2025 Half-Year Report, Details Access Conditions
29 Jul 2025 //
GLOBENEWSWIRE
DBV Tech Publishes H1 Liquidity Contract Report with ODDO BHF
28 Jul 2025 //
GLOBENEWSWIRE
DBV Technologies Appoints James Briggs as Chief HR Officer
22 Jul 2025 //
GLOBENEWSWIRE
DBV Technologies Screens First Subject in Peanut Allergy Study
25 Jun 2025 //
GLOBENEWSWIRE
DBV Technologies to Participate in Upcoming EAACI Congress 2025
12 Jun 2025 //
GLOBENEWSWIRE
DBV Technologies Announces 2025 Meeting Voting Results
11 Jun 2025 //
GLOBENEWSWIRE
Company`s Voting Rights and Shares as of May 30, 2025
04 Jun 2025 //
GLOBENEWSWIRE
DBV Technologies files addendum to 2024 Registration Document
03 Jun 2025 //
GLOBENEWSWIRE
Company`s voting rights and shares as of April 30, 2025
06 May 2025 //
GLOBENEWSWIRE
DBV Technologies at Citizens JMP Life Sciences Conference
05 May 2025 //
GLOBENEWSWIRE
DBV Technologies Reports First Quarter 2025 Financial Results
30 Apr 2025 //
GLOBENEWSWIRE
DBV Technologies files 2024 Annual Report on Form 10-K
11 Apr 2025 //
GLOBENEWSWIRE
DBV Technologies secures $306.9M for Viaskin Peanut Patch launch
27 Mar 2025 //
GLOBENEWSWIRE
DBV Technologies reaches FDA agreement on Viaskin Peanut Patch
24 Mar 2025 //
GLOBENEWSWIRE
DBV Technologies at AAAAI/WAO Joint Congress
25 Feb 2025 //
GLOBENEWSWIRE
Half-Year Report on DBV Tech Liquidity Contract with ODDO BHF
13 Jan 2025 //
GLOBENEWSWIRE
DBV Technologies Posts Positive 3-Year Epitope Study Results
08 Jan 2025 //
GLOBENEWSWIRE
DBV Confirms FDA Alignment on Viaskin® Peanut Patch for Toddlers
11 Dec 2024 //
GLOBENEWSWIRE
DBV Technologies Announces Plan to Implement ADS Ratio Change
11 Nov 2024 //
GLOBENEWSWIRE
DBV Technologies Reports Q3 2024 Financial Results
06 Nov 2024 //
GLOBENEWSWIRE
DBV Announces Positive Regulatory Updates For Viaskin® Peanut Patch
22 Oct 2024 //
GLOBENEWSWIRE
DBV Technologies to Participate in Upcoming ACAAI 2024 Congress
18 Oct 2024 //
GLOBENEWSWIRE
Information of Voting Rights And Shares Of Company As Of Sept 30
14 Oct 2024 //
GLOBENEWSWIRE
DBV Technologies Completes VITESSE Phase 3 Trial Screening
23 Sep 2024 //
GLOBENEWSWIRE
DBV Technologies To Join H.C. Wainwright Investment Conference
04 Sep 2024 //
GLOBENEWSWIRE
DBV Technologies Reports Total Voting Rights And Shares As Of July 31, 2024
02 Aug 2024 //
GLOBENEWSWIRE
DBV Technologies Updates Viaskin Peanut Program And Reports Q2 Results
30 Jul 2024 //
GLOBENEWSWIRE
DBV Technologies Files 2024 Half-Year Report
30 Jul 2024 //
GLOBENEWSWIRE
DBV Technologies To Report Q2 2024 Results And Business Update July 30
29 Jul 2024 //
GLOBENEWSWIRE
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
08 Jul 2024 //
GLOBENEWSWIRE
DBV Technologies: Attending Goldman Sachs Healthcare Event
05 Jun 2024 //
GLOBENEWSWIRE
Voting Rights/Shares: Information As Of May 31, 2024
04 Jun 2024 //
GLOBENEWSWIRE
DBV Technologies Announces Plan to Implement ADS Ratio Change
31 May 2024 //
GLOBENEWSWIRE
DBV Technologies to Participate in Upcoming EAACI 2024 Congress
30 May 2024 //
GLOBENEWSWIRE
DBV Technologies Announces Plan to Implement ADS Ratio Change
17 May 2024 //
GLOBENEWSWIRE
DBV Technologies Announces Results of its 2024 Combined General Meeting
16 May 2024 //
GLOBENEWSWIRE
DBV Technologies to Participate in Upcoming Investor Conferences
09 May 2024 //
GLOBENEWSWIRE
DBV Technologies Q1 2024 Results and Business Update
06 May 2024 //
GLOBENEWSWIRE
Combined General Meeting of May 16, 2024
25 Apr 2024 //
GLOBENEWSWIRE
Info regarding the total number of voting rights and total number of shares
04 Apr 2024 //
GLOBENEWSWIRE
DBV Technologies announces filing of 2023 Annual Report
08 Mar 2024 //
GLOBENEWSWIRE
DBV Technologies Reports Full Year 2023 Financial Results and Business Update
07 Mar 2024 //
GLOBENEWSWIRE
DBV Technologies to Report Full Year 2023 Financial Results
04 Mar 2024 //
GLOBENEWSWIRE
DBV Technologies to Participate in Upcoming AAAAI 2024 Congress
20 Feb 2024 //
GLOBENEWSWIRE
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
16 Jan 2024 //
GLOBENEWSWIRE
DBV Technologies Announces 2-Year Results from Phase 3 to the EPITOPE Trial
09 Nov 2023 //
GLOBENEWSWIRE
Monthly information regarding the total number of voting rights
06 Nov 2023 //
GLOBENEWSWIRE
DBV Technologies to Present New Data at ACAAI 2023
02 Nov 2023 //
GLOBENEWSWIRE
DBV Technologies Reports Third Quarter 2023 Financial Results
31 Oct 2023 //
GLOBENEWSWIRE
DBV Technologies to Report Third Quarter 2023 Financial Results
27 Oct 2023 //
GLOBENEWSWIRE
DBV Technologies Announces Appointment of Virginie Boucinha as CFO
16 Oct 2023 //
GLOBENEWSWIRE
Monthly information regarding the total number of voting rights
05 Oct 2023 //
GLOBENEWSWIRE
DBV Technologies to Participate in Upcoming Investor Conference
05 Sep 2023 //
GLOBENEWSWIRE
DBV Technologies Reports Second Quarter and Half-Year 2023 Financial Results
31 Jul 2023 //
GLOBENEWSWIRE
DBV Technologies to Report First Half 2023 Financial Results
25 Jul 2023 //
GLOBENEWSWIRE
Monthly information regarding the total number of voting rights
19 Jul 2023 //
GLOBENEWSWIRE
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
10 Jul 2023 //
GLOBENEWSWIRE
Monthly information regarding the total number of voting rights & total number
16 Jun 2023 //
GLOBENEWSWIRE
DBV Technologies Announces New England Journal of Medicine Publication
10 May 2023 //
GLOBENEWSWIRE
